| NCT ID | NCT06662409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Michigan State University |
| Condition | Bereavement |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-06-01 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Friend and family caregivers of recently deceased cancer patients experience acute bereavement following the death. Post death bereavement is an intense period of mourning that includes an unfolding of the grief process and is characterized by strong emotions and demands on cognitive resources to those who have put aside their own needs to support the dying patient with cancer. This research will test the feasibility and acceptability of a nature-based healing meditation (NBHM) intervention to support cancer caregivers' during the bereavement process.
Eligibility Criteria
Inclusion Criteria: * 18 years old or older; Able and willing to provide reflexology * Able to speak and understand English * Have access to a telephone * Able to hear normal conversation * Cognitively oriented to time, place, and person (determined via recruiter) Exclusion Criteria: * Unwilling to perform return demonstration with 90% accuracy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06662409 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bereavement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06662409 currently recruiting?
Yes, NCT06662409 is actively recruiting participants. Contact the research team at lehtor@msu.edu for enrollment information.
Where is the NCT06662409 trial being conducted?
This trial is being conducted at East Lansing, United States.
Who is sponsoring the NCT06662409 clinical trial?
NCT06662409 is sponsored by Michigan State University. The trial plans to enroll 70 participants.